Literature DB >> 9619389

Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study.

G Ragnarsson1, G Bodemar.   

Abstract

OBJECTIVES: To study the intensity and variation of pain and its temporal relation to eating and defaecation. Furthermore, what irritable bowel (IBS) patients mean by constipation and diarrhea and how bowel symptoms vary.
DESIGN: Prospective daily symptom recording over 6 weeks.
SETTING: The primary catchment area of University Hospital of Linköping. PARTICIPANTS: Eighty consecutive patients fulfilling the Rome criteria; 63 finished the study.
RESULTS: Fifty-nine of 63 patients recorded an average of 29 pain periods and 24 days with pain during the 6 weeks. Over-all pain burden decreased slightly over the study period. At inclusion 38 (64%) patients claimed that pain was relieved by defaecation. However, on average, only 10% of each patient's recorded pain periods were relieved by defaecation. At inclusion 29 (49%) patients claimed postprandial worsening of pain. On average, 50% of each patient's recorded pain periods worsened postprandially. The patients defined constipation as hard stools and diarrhea as loose stools and urgency. Stool frequency did not differ. Bowel symptoms varied within, but not between, fortnightly periods.
CONCLUSIONS: Postprandial worsening of pain should be included as a criterion in the clinical definition of IBS while the criterion 'pain relieved by defaecation' should be re-evaluated. IBS patients can probably be divided into subgroups based on stool consistency, not frequency. Daily records are superior to structured clinical interviews or questionnaires for a detailed study of symptoms in IBS.

Entities:  

Mesh:

Year:  1998        PMID: 9619389     DOI: 10.1097/00042737-199805000-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  45 in total

Review 1.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  Of actors, bolting horses, and drops in oceans!

Authors:  F Cremonini; M Camilleri
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.

Authors:  Olafur S Palsson; Jeffrey S Baggish; Marsha J Turner; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2011-11-08       Impact factor: 10.864

4.  Lack of an Effect of Gastric Capsaicin on the Rectal Component of the Gastrocolonic Response.

Authors:  Martina Führer; Johann Hammer
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

5.  Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.

Authors:  Seon-Young Park; Min-Ho Park; Kyoung-Won Yoon; Sung-Bum Cho; Wan-Sik Lee; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

6.  Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities.

Authors:  Keren Hod; Yehuda Ringel; Miranda A L van Tilburg; Tamar Ringel-Kulka
Journal:  Dig Dis Sci       Date:  2018-12-18       Impact factor: 3.199

7.  Current and emerging therapies for the management of functional gastrointestinal disorders.

Authors:  Orla F Craig; Eamonn M M Quigley
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

8.  The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.

Authors:  Pontus Karling; Åke Danielsson; Mikael Wikgren; Ingegerd Söderström; Jurgen Del-Favero; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 9.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

10.  Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.

Authors:  Annemie Deiteren; Michael Camilleri; Duane Burton; Sanna McKinzie; Archana Rao; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.